<p>The invention relates to live attenuated VDV2 (VERO-Derived Vaccine Dengue serotype 2) strains which have been derived from the wild-type dengue-2 strain 16681 by passaging on PDK and Vero cells. The invention further relates to a vaccine composition which comprises a VDV2 strain.</p>
申请公布号
AU2006257621(B2)
申请公布日期
2011.08.11
申请号
AU20060257621
申请日期
2006.06.07
申请人
CENTERS FOR DISEASE CONTROL AND PREVENTION;SANOFI PASTEUR
